RD-Biotech, a complete platform from DNA to antibody

For your antibody development projects, for applications in immunotherapy, diagnostics, research: contact our team of experts in molecular biology and antibody engineering.

Contact us for more information!

RD-Biotech is here to help you in your projects related to Covid-19!

Development / Production of monoclonal or recombinant antibodies - Expression vector construction - Antigen expression - DNA plasmid production...

Contact us for more information!

Our sister company, Diaclone, is now part of the Medix Biochemica group

Biotech Investissement (www.mabexperts.com) separates from its subsidiary Diaclone by selling it to Medix Biochemica.

The arrival of Diaclone in the Medix group will allow it to access new international markets, and therefore to continue its growth in the In Vitro Diagnostics (IVD) market.

Our group will now focus on the development of biomanufacturing services for plasmid DNAs, antibodies and recombinant proteins with in particular the upcoming construction of a new DNA production unit, GMP grade (BPF) at RD-BIOTECH.

More information: Biotech Investissement communication
Contact us: info@rd-biotech.com

08 february 2021

RD-Biotech winner of the call for projects of France Relance!

RD-BIOTECH, sees its project to build a production unit "Plasmids GMP" selected by the French State as the winner of the call for projects "AAP Recovery Plan for Industry - Strategic Sectors".
This production unit will complement our current plasma DNA bioproduction capabilities, R&D grade and "High Quality Grade", to meet a very fast growing demand of the new therapies market.

Contact us for more information!